Apollo Management Holdings
EBACW

Apollo Management Holdings’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Apollo Management Holdings’s Portfolio EBACW Stock Details EBACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,260
Closed -$20K – 425
2021
Q4 		$20K Buy
+33,260
New +$21.3K ﹤0.01% 258

Other funds holding EBACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Sculptor Capital
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Apollo Management Holdings's EBACW Position: Q1 2022 in Review

Apollo Management Holdings sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2022, closing a stake of 33,260 shares — an estimated $20K sold.

Apollo Management Holdings first reported a position in EBACW in Q4 2021 and held it in 1 quarter. The position peaked at $20K in Q4 2021. 30 funds tracked by Wall St. Rank hold EBACW as of Q1 2022.

  • Apollo Management Holdings reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2022 after selling out during the quarter.
  • Apollo Management Holdings sold 33,260 European Biotech Acquisition Corp. Warrant shares in Q1 2022, an estimated $20K.
  • Apollo Management Holdings first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2021 and held it in 1 quarter.
  • Apollo Management Holdings's European Biotech Acquisition Corp. Warrant position peaked at $20K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2022.

Based on Apollo Management Holdings's 13F filing for Q1 2022, filed 16 May 2022.